Sandu Pharmaceuticals Management
Management criteria checks 2/4
Sandu Pharmaceuticals' CEO is Umesh Sandu, appointed in Jun 2018, has a tenure of 5.92 years. total yearly compensation is ₹8.93M, comprised of 94.6% salary and 5.4% bonuses, including company stock and options. directly owns 14.37% of the company’s shares, worth ₹85.50M. The average tenure of the management team and the board of directors is 3 years and 3.3 years respectively.
Key information
Umesh Sandu
Chief executive officer
₹8.9m
Total compensation
| CEO salary percentage | 94.6% |
| CEO tenure | 5.9yrs |
| CEO ownership | 14.4% |
| Management average tenure | 3yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹11m |
| Sep 30 2023 | n/a | n/a | ₹14m |
| Jun 30 2023 | n/a | n/a | ₹15m |
| Mar 31 2023 | ₹9m | ₹8m | ₹15m |
| Dec 31 2022 | n/a | n/a | ₹15m |
| Sep 30 2022 | n/a | n/a | ₹15m |
| Jun 30 2022 | n/a | n/a | ₹16m |
| Mar 31 2022 | ₹7m | ₹7m | ₹16m |
| Dec 31 2021 | n/a | n/a | ₹17m |
| Sep 30 2021 | n/a | n/a | ₹15m |
| Jun 30 2021 | n/a | n/a | ₹15m |
| Mar 31 2021 | ₹4m | ₹3m | ₹11m |
| Dec 31 2020 | n/a | n/a | ₹7m |
| Sep 30 2020 | n/a | n/a | ₹6m |
| Jun 30 2020 | n/a | n/a | ₹4m |
| Mar 31 2020 | ₹4m | ₹3m | ₹7m |
| Dec 31 2019 | n/a | n/a | ₹7m |
| Sep 30 2019 | n/a | n/a | ₹6m |
| Jun 30 2019 | n/a | n/a | ₹7m |
| Mar 31 2019 | ₹4m | ₹3m | ₹7m |
| Dec 31 2018 | n/a | n/a | ₹9m |
| Sep 30 2018 | n/a | n/a | ₹14m |
| Jun 30 2018 | n/a | n/a | ₹14m |
| Mar 31 2018 | ₹3m | ₹3m | ₹6m |
Compensation vs Market: Umesh's total compensation ($USD106.95K) is above average for companies of similar size in the Indian market ($USD39.30K).
Compensation vs Earnings: Umesh's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Umesh Sandu (56 yo)
5.9yrs
Tenure
₹8,927,520
Compensation
Mr. Umesh Bhaskar Sandu serves as the Managing Director and Executive Director of Sandu Pharmaceuticals Limited since June 2, 2018 and served as its Company Secretary.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 5.9yrs | ₹8.93m | 14.37% ₹ 85.5m | |
| Compliance Officer & Company Secretary | 9.1yrs | ₹773.00k | no data | |
| Executive Chairman | less than a year | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data |
3.0yrs
Average Tenure
Experienced Management: 524703's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 5.9yrs | ₹8.93m | 14.37% ₹ 85.5m | |
| Executive Chairman | less than a year | no data | no data | |
| Non-Executive Director | 12.9yrs | ₹51.00k | 14.17% ₹ 84.3m | |
| Non-Executive Director | 9.1yrs | ₹30.00k | 0.10% ₹ 615.7k | |
| Non-Executive Independent Director | less than a year | no data | no data | |
| Non Executive Independent Chairman | less than a year | no data | no data |
3.3yrs
Average Tenure
59yo
Average Age
Experienced Board: 524703's board of directors are considered experienced (3.3 years average tenure).